Inflammatory bowel disease

Stephen B. Hanauer; Daan W. Hommes

doi:10.1586/eci.10.52

Inflammatory bowel disease

Stephen B. Hanauer, Daan W. Hommes

Medicine, Gastroenterology Division

Research output: Contribution to journal › Editorial › peer-review

4 Scopus citations

Original language	English (US)
Pages (from-to)	499-500
Number of pages	2
Journal	Expert Review of Clinical Immunology
Volume	6
Issue number	4
DOIs	https://doi.org/10.1586/eci.10.52
State	Published - Jul 2010

ASJC Scopus subject areas

Immunology and Allergy
Immunology

Access to Document

10.1586/eci.10.52

Cite this

@article{099e6ca33b2b439da91bfd57696ac0d8,

title = "Inflammatory bowel disease",

author = "Hanauer, {Stephen B.} and Hommes, {Daan W.}",

note = "Funding Information: Stephen B Hanauer works as a consultant for Alevan, Amgen, Astellas Pharma Global, AstraZeneca, GSK, McNeil PPC, Millenium Pharmaceuticals, Novartis, Novo Nordisk and Takeda. He also works as a consultant and in clinical research for Abbott Labs, Bristol Myers Squibb, Centocor, Chemocentryx, Elan, Ferring, Genentech, Pfizer, Prometheus, Salix, Shire, Therakos, UCB Pharma and Warner-Chilcott. Daan W Hommes works as a consultant for Abbott Labs, Centocor, MSD and UCB, and recieves research grants from Abbott Labs, Centocor, MSD, UCB, Ferring, Giuliani Pharma and FALK. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.",

year = "2010",

month = jul,

doi = "10.1586/eci.10.52",

language = "English (US)",

volume = "6",

pages = "499--500",

journal = "Expert Review of Clinical Immunology",

issn = "1744-666X",

publisher = "Expert Reviews Ltd.",

number = "4",

}

TY - JOUR

T1 - Inflammatory bowel disease

AU - Hanauer, Stephen B.

AU - Hommes, Daan W.

N1 - Funding Information: Stephen B Hanauer works as a consultant for Alevan, Amgen, Astellas Pharma Global, AstraZeneca, GSK, McNeil PPC, Millenium Pharmaceuticals, Novartis, Novo Nordisk and Takeda. He also works as a consultant and in clinical research for Abbott Labs, Bristol Myers Squibb, Centocor, Chemocentryx, Elan, Ferring, Genentech, Pfizer, Prometheus, Salix, Shire, Therakos, UCB Pharma and Warner-Chilcott. Daan W Hommes works as a consultant for Abbott Labs, Centocor, MSD and UCB, and recieves research grants from Abbott Labs, Centocor, MSD, UCB, Ferring, Giuliani Pharma and FALK. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

PY - 2010/7

Y1 - 2010/7

UR - http://www.scopus.com/inward/record.url?scp=77954393288&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77954393288&partnerID=8YFLogxK

U2 - 10.1586/eci.10.52

DO - 10.1586/eci.10.52

M3 - Editorial

C2 - 20594118

AN - SCOPUS:77954393288

SN - 1744-666X

VL - 6

SP - 499

EP - 500

JO - Expert Review of Clinical Immunology

JF - Expert Review of Clinical Immunology

IS - 4

ER -

Inflammatory bowel disease

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this